Mirae Asset Global ETFs Holdings’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
Mirae Asset Global ETFs Holdings's IRMD Position: Q1 2026 in Review
Mirae Asset Global ETFs Holdings increased its iRadimed (IRMD) stake by 1.8% in Q1 2026, buying an estimated $6.9K and bringing the position to 3,830 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #2045.
Mirae Asset Global ETFs Holdings first reported a position in IRMD in Q2 2024 and has held it in 8 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Mirae Asset Global ETFs Holdings held 3,830 shares of iRadimed worth $369K as of Q1 2026.
- Mirae Asset Global ETFs Holdings bought 69 iRadimed shares in Q1 2026, an estimated $6.9K.
- iRadimed made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2045 holding.
- Mirae Asset Global ETFs Holdings first reported a position in iRadimed in Q2 2024 and has held it in 8 quarters since.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.